Farley J. Abad

Array ( [id] => 7445794 [patent_doc_number] => 20040009613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Methods of identifying modulators of bromodomains' [patent_app_type] => new [patent_app_number] => 10/209201 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 26682 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009613.pdf [firstpage_image] =>[orig_patent_app_number] => 10209201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750976 [patent_doc_number] => 20030045497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Methylation resistant vectors' [patent_app_type] => new [patent_app_number] => 10/206557 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10395 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045497.pdf [firstpage_image] =>[orig_patent_app_number] => 10206557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406482 [patent_doc_number] => 20040024193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method of detecting and quantifying hepatitis C virus' [patent_app_type] => new [patent_app_number] => 10/207693 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10005 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024193.pdf [firstpage_image] =>[orig_patent_app_number] => 10207693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1177920 [patent_doc_number] => 06743772 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-01 [patent_title] => 'Use of parovirus capsid particles in the inhibition of cell proliferation and migration' [patent_app_type] => B1 [patent_app_number] => 10/200616 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14223 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743772.pdf [firstpage_image] =>[orig_patent_app_number] => 10200616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1086101 [patent_doc_number] => 06831158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-14 [patent_title] => 'G-CSF conjugates' [patent_app_type] => B2 [patent_app_number] => 10/192294 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38229 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/831/06831158.pdf [firstpage_image] =>[orig_patent_app_number] => 10192294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787219 [patent_doc_number] => 20030138458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'HCV E1E2 vaccine compositions' [patent_app_type] => new [patent_app_number] => 10/187257 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17947 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138458.pdf [firstpage_image] =>[orig_patent_app_number] => 10187257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 748600 [patent_doc_number] => 07022323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 10/184150 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 33951 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022323.pdf [firstpage_image] =>[orig_patent_app_number] => 10184150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846349 [patent_doc_number] => 20030165516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens' [patent_app_type] => new [patent_app_number] => 10/180593 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14122 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165516.pdf [firstpage_image] =>[orig_patent_app_number] => 10180593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846299 [patent_doc_number] => 20030165466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Recombinant poliovirus for the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/175247 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14653 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165466.pdf [firstpage_image] =>[orig_patent_app_number] => 10175247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297951 [patent_doc_number] => 20040214994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein nucleic acid and uses thereof' [patent_app_type] => new [patent_app_number] => 10/480843 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5296 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214994.pdf [firstpage_image] =>[orig_patent_app_number] => 10480843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668765 [patent_doc_number] => 20030113748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins' [patent_app_type] => new [patent_app_number] => 10/161613 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5798 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113748.pdf [firstpage_image] =>[orig_patent_app_number] => 10161613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821591 [patent_doc_number] => 20030219752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof' [patent_app_type] => new [patent_app_number] => 10/151469 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 96 [patent_figures_cnt] => 96 [patent_no_of_words] => 202555 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219752.pdf [firstpage_image] =>[orig_patent_app_number] => 10151469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652971 [patent_doc_number] => 20030008813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Intracellular protein delivery compositions and methods of use' [patent_app_type] => new [patent_app_number] => 10/141535 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10799 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008813.pdf [firstpage_image] =>[orig_patent_app_number] => 10141535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208429 [patent_doc_number] => 06713078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Retrocyclins: antiviral and antimicrobial peptides' [patent_app_type] => B2 [patent_app_number] => 10/141645 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 19520 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713078.pdf [firstpage_image] =>[orig_patent_app_number] => 10141645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716663 [patent_doc_number] => 20030028011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs' [patent_app_type] => new [patent_app_number] => 10/139069 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26939 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20030028011.pdf [firstpage_image] =>[orig_patent_app_number] => 10139069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426581 [patent_doc_number] => 20040265792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Agents for treatment of hcv and methods of use' [patent_app_type] => new [patent_app_number] => 10/481261 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8987 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265792.pdf [firstpage_image] =>[orig_patent_app_number] => 10481261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633245 [patent_doc_number] => 20030211477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening' [patent_app_type] => new [patent_app_number] => 10/138176 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 93341 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211477.pdf [firstpage_image] =>[orig_patent_app_number] => 10138176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778195 [patent_doc_number] => 20030049276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation' [patent_app_type] => new [patent_app_number] => 10/132460 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6740 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049276.pdf [firstpage_image] =>[orig_patent_app_number] => 10132460 [rel_patent_id] =>[rel_patent_doc_number] =>)